New T Top Line Data | HZNP Message Board Posts

Horizon Pharma, Inc.

  HZNP website

HZNP   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1881 of 1893  at  7/31/2020 7:15:41 PM  by

geringerart


New T Top Line Data

89% in OPTIC and OPTIC-X trials (OPTIC-X gave T to placebo recipients from OPTIC). Redosing for relapsed patients also showed results.

Took questions but since Q2 CC is next week they only focused on the trial results and wouldn't talk about impact on earnings, etc. My take is that the $1B plus peak market for T will be greatly increased due to retreatments. Hope to hear more on this at the Q2 (likely will) and possibly increased projections for this year and peak sales.

Worth listening to the presentation if you get a chance. Some of the photos of TED patients are graphic, so be warned.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 75
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1882 Re: New T Top Line Data drugfree 0 7/31/2020 7:29:33 PM






Financial Market Data provided by
.


Loading...